Publication | Open Access
Novel Role of Lck in Leptin-Induced Inflammation and Implications for Renal Aging
18
Citations
17
References
2019
Year
ImmunologyRenal InflammationImmune RegulationCell DeathLeptin-induced InflammationInflammationRenal FunctionNovel RoleHypothalamic PeptideMetabolic SignalingChronic Kidney DiseaseKidney ResearchCell SignalingMolecular SignalingMolecular PhysiologyLeptin SignalingChronic InflammationVascular BiologyImmune FunctionRenal PathophysiologyEndocrinologyInflammatory DiseaseCell BiologyCytokineUrologyPhysiologyProtein Tyrosine KinaseSerum Leptin LevelsMedicineRenal AgingNephrologyGeriatric Endocrinology
Aging is associated with increased fat mass and elevated serum leptin levels (hyperleptinemia), causing proinflammation in the kidneys where it plays a primary role in the removal of endogenous leptin from the circulation. Lymphocyte-specific kinase (Lck) is a positive regulator of inflammatory signaling and a potential treatment target for age-related diseases, but its role in leptin signaling is unknown. Here, we investigated how Lck influences hyperleptinemia-induced inflammation in kidney tissues from 6- and 21-month-old rats. Results indicate that Lck expression and activation increased significantly in aged rat kidneys, especially at renal tubules. Furthermore, we identified interactions between Lck and short leptin-receptor isoforms, suggesting that Lck is a protein tyrosine kinase regulating leptin signaling. We further investigated whether increased Lck expression in renal tubular epithelial cells and macrophage infiltration are associated with leptin-induced inflammation. We then demonstrated that leptin activates Lck and proinflammatory transcription factors (STAT3 and NF-κB), while Lck knockdown modulates the expression of both transcription factors. Collectively, these data implicate that Lck leads to development of leptin-induced renal inflammation during aging. Inhibition of this protein tyrosine kinase may therefore be an appropriate therapeutic option for protection against age-related hyperleptinemia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1